Genevieve C. Kendall

Genevieve C. Kendall studies rhabdomyosarcoma, a pediatric cancer of muscle-like tissue, focusing on how a specific fusion gene (PAX::FOXO1) reprograms cells and drives tumor formation. Her lab uses zebrafish models and genomic/chromatin analysis tools to understand the biological mechanisms behind this cancer and to identify potential therapeutic targets. This work combines developmental biology, cancer genomics, and model organism engineering to study how fusion oncogenes alter cell identity and behavior.

Publication output has grown substantially over the past decade, rising from sporadic early activity to a sustained high output of roughly 6-11 papers per year since 2023.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026